Form 8-K Caribou Biosciences, For: Jun 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Citi Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU)
June 3, 2024 8:10 AM EDTCiti analyst Yigal Nochomovitz reiterated a Buy rating and $30.00 price target on Caribou Biosciences Inc. (NASDAQ: CRBU)
The analyst comments "CRBUs retrospective introduction of a partial HLA-matching strategy for CB-010 (allogeneic CD19 CAR-T) seems be bearing fruit with the reported 14.4-month PFS in patients... More
Evercore ISI Downgrades Caribou Biosciences Inc. (CRBU) to In Line
June 3, 2024 6:25 AM EDTEvercore ISI analyst Liisa Bayko downgraded Caribou Biosciences Inc. (NASDAQ: CRBU) from Outperform to In Line with a price target of $3.00 (from $13.00).
The analyst comments "CRBU may have unlocked the key to allogenic CAR-T. But we are not yet convinced that it will be... More



